BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 78 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2016 | $1,863,000 | -34.6% | 53,484 | -19.2% | 0.00% | -40.0% |
Q4 2015 | $2,848,000 | +8.3% | 66,229 | +9.7% | 0.01% | 0.0% |
Q3 2015 | $2,630,000 | +91.1% | 60,387 | +126.3% | 0.01% | +150.0% |
Q2 2015 | $1,376,000 | -17.0% | 26,686 | -37.0% | 0.00% | -33.3% |
Q1 2015 | $1,657,000 | -7.8% | 42,329 | -10.3% | 0.00% | 0.0% |
Q4 2014 | $1,797,000 | +1114.2% | 47,200 | +1026.5% | 0.00% | – |
Q3 2014 | $148,000 | – | 4,190 | +13866.7% | 0.00% | – |
Q2 2013 | $0 | – | 30 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JW Asset Management, LLC | 73,649 | $3,646,000 | 2.32% |
Stonepine Capital Management, LLC | 59,878 | $2,965,000 | 1.60% |
NORTHPOINTE CAPITAL LLC | 109,644 | $5,428,000 | 0.57% |
Elk Creek Partners, LLC | 145,406 | $7,199,000 | 0.47% |
TFS CAPITAL LLC | 18,208 | $901,000 | 0.35% |
RICE HALL JAMES & ASSOCIATES, LLC | 161,671 | $8,004,000 | 0.35% |
Ativo Capital Management LLC | 19,592 | $970,000 | 0.26% |
Matarin Capital Management, LLC | 57,034 | $2,823,753,000 | 0.26% |
ISTHMUS PARTNERS, LLC | 16,505 | $817,000 | 0.24% |
Stanley-Laman Group, Ltd. | 12,546 | $621,000 | 0.17% |